Obesity

Recent studies evaluate risks associated with drugs such as Wegovy and Mounjaro

Insurance plans could cover blockbuster weight-loss medications such as Wegovy and Ozempic, but the benefits may not be accessible to everyone

The new social media trend “budget Ozempic” promotes laxatives and stool softeners for weight loss, but these drugs are dangerous if misused

Clinical-trial data suggest that semaglutide, sold under the name Wegovy, slashed risk of heart attacks and other cardiovascular incidents in a trial

Limited data on adults age 60 and older raise questions on whether high-priced weight-loss drugs will really help with lowering rates of chronic illness and disability

Here’s why your body sheds fat and muscle when you diet

A leading medical society says that the commonly used body mass index falls short, and it is time for alternative measures

Researchers hope their work on racial health disparities will be a “call to action”

Data show that smoking, drinking alcohol and having a high body mass index are the biggest contributors to cancer worldwide

In an August 2022 study, participants who consumed sugar substitutes showed an altered microbiome and spikes in blood glucose

Weight bias compounds health problems, and surgeons need to recognize and stop it

For decades, assumptions about weight have clouded our view of health